barr 955 Pill: brown, capsule/oblong, 14mm
The pill with imprint barr 955 (Brown, Capsule/Oblong, 14mm) has been identified as Dextroamphetamine Sulfate Extended Release 10 mg and is used for ADHD, and Narcolepsy. It belongs to the drug class CNS stimulants and is classified as CSA Schedule 2 (High potential for abuse).
Images for barr 955



Dextroamphetamine Sulfate Extended Release
- Imprint
- barr 955
- Strength
- 10 mg
- Color
- Brown
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00555-0955 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
dibutyl sebacate,
methylcellulose (15 mPa.s),
povidone k30,
propylene glycol,
sucrose,
corn starch,
magnesium silicate,
ferrosoferric oxide,
ferric oxide red,
titanium dioxide,
ferric oxide yellow,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
shellac
Note: Inactive ingredients may vary.
See also:
More about dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (297)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
- Dextroamphetamine drug information
- Dextroamphetamine Tablets
- Dextroamphetamine Sustained-Release Capsules
- Dextroamphetamine Oral Solution
Other brands
Dexedrine, Zenzedi, Xelstrym, Dextrostat, ... +2 more
Professional resources
- Dextroamphetamine monograph
- Dextroamphetamine (FDA)
- Dextroamphetamine ER (FDA)
- Dextroamphetamine Extended-Release Capsules (FDA)
- Dextroamphetamine Oral Solution (FDA)
Other brands
Dexedrine, Zenzedi, Xelstrym, Dextrostat, ProCentra
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.